ETONOGESTREL

ETONOGESTREL was reported 57571 times

ETONOGESTREL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMPLANT SITE INJURY 135 0.9184
1 IMPLANT SITE HYPOAESTHESIA 191 0.9052
2 IMPLANT SITE HYPERAESTHESIA 9 0.9000
3 IMPLANT SITE EXFOLIATION 7 0.8750
4 IMPLANT SITE URTICARIA 83 0.8469
5 IMPLANT SITE BRUISING 631 0.8425
6 IMPLANT SITE PARAESTHESIA 125 0.8333
7 IMPLANT SITE PAPULES 20 0.8333
8 IMPLANT SITE PRURITUS 742 0.8244
9 IMPLANT SITE COLDNESS 8 0.8000
10 DIFFICULTY REMOVING DRUG IMPLANT 144 0.8000
11 MEDICAL DEVICE SITE MOVEMENT IMPAIRMENT 8 0.8000
12 IMPLANT SITE PUSTULES 48 0.7869
13 IMPLANT SITE IRRITATION 298 0.7863
14 LIPOLYSIS PROCEDURE 7 0.7778
15 MIGRATION OF IMPLANTED DRUG 408 0.7742
16 IMPLANT SITE DISCOLOURATION 119 0.7727
17 IMPLANT SITE RASH 265 0.7402
18 IMPLANT SITE FIBROSIS 371 0.7390
19 PREGNANCY WITH IMPLANT CONTRACEPTIVE 3434 0.7317
20 SKIN IMPLANT REMOVAL 8 0.7273
21 IMPLANT SITE PAIN 3247 0.7259
22 IMPLANT SITE ERYTHEMA 747 0.7203
23 IMPLANT SITE VESICLES 105 0.7143
24 IMPLANT SITE SCAR 523 0.6992
25 DEVICE EMBOLISATION 202 0.6847
26 IMPLANT SITE INDURATION 78 0.6842
27 IMPLANT SITE CELLULITIS 157 0.6709
28 IMPLANT SITE NODULE 28 0.6667
29 IMPLANT SITE HYPERSENSITIVITY 72 0.6486
30 DEVICE KINK 2340 0.6416
31 DEVICE PLACEMENT ERROR 7 0.6364
32 IMPLANT SITE NERVE INJURY 20 0.6250
33 IMPLANT SITE MASS 121 0.6142
34 CONTRACEPTIVE IMPLANT 18 0.6000
35 IMPLANT SITE WARMTH 90 0.5806
36 IMPLANT SITE SWELLING 581 0.5702
37 IMPLANT SITE HAEMORRHAGE 251 0.5653
38 IMPLANT SITE DERMATITIS 10 0.5556
39 GENERAL ANAESTHESIA 242 0.5366
40 FALSE NEGATIVE PREGNANCY TEST 16 0.5333
41 ENCAPSULATION REACTION 52 0.5049
42 IMPLANT SITE ABSCESS 96 0.4974
43 MENSTRUATION NORMAL 164 0.4940
44 MEDICAL DEVICE SITE DISCOMFORT 389 0.4844
45 IMPLANT SITE CYST 13 0.4815
46 IMPLANT SITE OEDEMA 46 0.4742
47 COMPLICATION ASSOCIATED WITH DEVICE 6622 0.4556
48 IMPLANT SITE INFLAMMATION 127 0.4334
49 MEDICAL DEVICE SITE SCAB 29 0.3973
50 IMPLANT SITE REACTION 177 0.3899
51 IMPLANT SITE DISCHARGE 144 0.3840
52 IMPLANT SITE NECROSIS 32 0.3636
53 UNINTENDED PREGNANCY 3743 0.3578
54 DEVICE PLACEMENT ISSUE 1268 0.3537
55 DEVICE IMPLANTATION ERROR 26 0.3059
56 IMPLANT SITE INFECTION 701 0.3011
57 MENOMETRORRHAGIA 570 0.2986
58 DEVICE DEPLOYMENT ISSUE 3686 0.2883
59 IMPLANT SITE ULCER 8 0.2759
60 ENDOMETRIAL THINNING 9 0.2571
61 COMPLICATION OF DEVICE REMOVAL 4373 0.2417
62 COMPLICATION OF DEVICE INSERTION 4758 0.2389
63 IMPLANT SITE THROMBOSIS 9 0.2368
64 INCORRECT PRODUCT ADMINISTRATION DURATION 5033 0.2321
65 IMPLANT SITE HAEMATOMA 55 0.2254
66 IMPLANTATION COMPLICATION 42 0.2019
67 HEAVY MENSTRUAL BLEEDING 1783 0.1980
68 ECTOPIC PREGNANCY TERMINATION 11 0.1746
69 POLYMENORRHOEA 592 0.1706
70 MENSTRUAL CLOTS 39 0.1625
71 DEVICE EXTRUSION 33 0.1549
72 ULNAR NERVE INJURY 35 0.1452
73 AMENORRHOEA 2545 0.1450
74 ADMINISTRATION SITE DISCOMFORT 26 0.1376
75 HYPOMENORRHOEA 373 0.1359
76 DEVICE BREAKAGE 5381 0.1324
77 MENORRHAGIA 2443 0.1243
78 OVULATION DISORDER 14 0.1197
79 MEDIAN NERVE INJURY 7 0.1129
80 NUCLEAR MAGNETIC RESONANCE IMAGING 18 0.1084
81 PREGNANCY TEST FALSE POSITIVE 50 0.1073
82 MEDICAL DEVICE COMPLICATION 743 0.1004
83 PREGNANCY TEST NEGATIVE 10 0.0952
84 OLIGOMENORRHOEA 206 0.0944
85 IMPLANT SITE DEHISCENCE 8 0.0930
86 MENSTRUATION IRREGULAR 2465 0.0919
87 KELOID SCAR 47 0.0911
88 MENSTRUATION DELAYED 985 0.0908
89 POLYMENORRHAGIA 7 0.0886
90 MENSTRUAL DISORDER 731 0.0882
91 VAGINAL HAEMORRHAGE 3434 0.0790
92 BREAST FEEDING 59 0.0755
93 UNWANTED PREGNANCY 10 0.0730
94 LIPOSUCTION 11 0.0719
95 METRORRHAGIA 1212 0.0710
96 UTERINE HAEMORRHAGE 297 0.0696
97 DEVICE DIFFICULT TO USE 4584 0.0692
98 PRODUCT QUALITY CONTROL ISSUE 14 0.0690
99 NO ADVERSE EVENT 12139 0.0669
100 DEVICE DISLOCATION 2893 0.0665
101 ECTOPIC PREGNANCY WITH CONTRACEPTIVE DEVICE 111 0.0651
102 INTERMENSTRUAL BLEEDING 361 0.0645
103 EXPLORATORY OPERATION 8 0.0620
104 IMPLANT SITE EROSION 18 0.0612
105 ABORTION OF ECTOPIC PREGNANCY 7 0.0583
106 LACTATION INSUFFICIENCY 12 0.0580
107 ABNORMAL MENSTRUAL CLOTS 10 0.0571
108 PREGNANCY ON CONTRACEPTIVE 83 0.0568
109 FEMALE STERILISATION 29 0.0564
110 DYSMENORRHOEA 676 0.0509
111 PRODUCT QUALITY ISSUE 6915 0.0509
112 INFERTILITY FEMALE 79 0.0508
113 THORACOTOMY 7 0.0490
114 FOREIGN BODY REACTION 12 0.0488
115 PATIENT-DEVICE INCOMPATIBILITY 33 0.0483
116 INCISION SITE IMPAIRED HEALING 19 0.0471
117 COITAL BLEEDING 72 0.0462
118 RUPTURED ECTOPIC PREGNANCY 35 0.0452
119 ABORTION INDUCED 421 0.0447
120 ANOVULATORY CYCLE 9 0.0435
121 SUPPRESSED LACTATION 32 0.0426
122 ADNEXA UTERI PAIN 54 0.0422
123 HIGH ARCHED PALATE 7 0.0409
124 VOMITING IN PREGNANCY 14 0.0386
125 INCORRECT DRUG ADMINISTRATION DURATION 1049 0.0373
126 BREAST ATROPHY 8 0.0360
127 DEVICE ALLERGY 9 0.0360
128 DEVICE EXPULSION 2329 0.0359
129 PREMENSTRUAL SYNDROME 48 0.0349
130 PREMENSTRUAL DYSPHORIC DISORDER 7 0.0345
131 APPLICATION SITE DISCOMFORT 62 0.0345
132 BREAST DISCHARGE 60 0.0342
133 DEVICE INTOLERANCE 8 0.0336
134 HORMONE LEVEL ABNORMAL 164 0.0336
135 PREGNANCY TEST POSITIVE 13 0.0331
136 BODY MASS INDEX ABNORMAL 8 0.0328
137 PROGESTERONE DECREASED 10 0.0322
138 VAGINAL DISCHARGE 310 0.0306
139 HYPOAESTHESIA EYE 18 0.0305
140 OVARIAN HAEMORRHAGE 7 0.0295
141 BREAST PAIN 314 0.0294
142 MOOD SWINGS 934 0.0293
143 IMPLANT SITE EXTRAVASATION 23 0.0293
144 ANEMBRYONIC GESTATION 6 0.0287
145 SLEEVE GASTRECTOMY 7 0.0285
146 MEDICAL DEVICE DISCOMFORT 86 0.0281
147 UTERINE PAIN 28 0.0273
148 INFERTILITY 41 0.0272
149 DYSFUNCTIONAL UTERINE BLEEDING 33 0.0272
150 PRODUCT PRESCRIBING ISSUE 586 0.0269
151 ABORTION 78 0.0267
152 VAGINAL ODOUR 33 0.0262
153 ABNORMAL UTERINE BLEEDING 67 0.0261
154 PRODUCT KNOWLEDGE DEFICIT 20 0.0256
155 BREAST TENDERNESS 188 0.0249
156 PERINATAL DEPRESSION 11 0.0244
157 MEDICAL DEVICE REMOVAL 42 0.0243
158 COMPLICATION OF DELIVERY 7 0.0242
159 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 24 0.0238
160 DEVICE ISSUE 2137 0.0238
161 HEPATIC ADENOMA 12 0.0232
162 MATERNAL EXPOSURE DURING BREAST FEEDING 94 0.0231
163 CHLAMYDIAL INFECTION 17 0.0225
164 DRUG-GENETIC INTERACTION 8 0.0224
165 MORNING SICKNESS 12 0.0220
166 METABOLIC SURGERY 25 0.0220
167 ENDOMETRIAL DISORDER 9 0.0218
168 ECTOPIC PREGNANCY 67 0.0218
169 PRODUCT INEFFECTIVE 17 0.0216
170 SKIN TURGOR DECREASED 8 0.0206
171 LACTATION DISORDER 10 0.0205
172 BACTERIAL VAGINOSIS 32 0.0204
173 VULVOVAGINAL DRYNESS 64 0.0198
174 OVARIAN CYST 197 0.0197
175 VULVOVAGINAL INFLAMMATION 9 0.0195
176 SALPINGECTOMY 11 0.0192
177 POLYCYSTIC OVARIES 29 0.0187
178 PLASTIC SURGERY 6 0.0185
179 NIPPLE PAIN 37 0.0182
180 INCISION SITE COMPLICATION 14 0.0168
181 ABORTION SPONTANEOUS 671 0.0167
182 AXILLARY PAIN 24 0.0161
183 SEXUALLY TRANSMITTED DISEASE 7 0.0161
184 VAGINAL INFECTION 74 0.0157
185 OVARIAN CYST RUPTURED 20 0.0156
186 CHOLESTASIS OF PREGNANCY 7 0.0152
187 DYSPAREUNIA 68 0.0148
188 IDIOPATHIC INTRACRANIAL HYPERTENSION 33 0.0147
189 BLOOD LOSS ANAEMIA 33 0.0146
190 BODY MASS INDEX INCREASED 19 0.0141
191 PRODUCT CLOSURE REMOVAL DIFFICULT 14 0.0137
192 FIBROADENOMA OF BREAST 6 0.0133
193 COMPLICATION OF PREGNANCY 10 0.0131
194 BREAST ENLARGEMENT 43 0.0131
195 MOOD ALTERED 358 0.0131
196 UTERINE SPASM 24 0.0131
197 CELLULITIS STAPHYLOCOCCAL 8 0.0123
198 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 32 0.0120
199 SUTURE INSERTION 7 0.0120
200 FAT TISSUE INCREASED 17 0.0117
201 MENINGOMYELOCELE 7 0.0117
202 DEVICE DAMAGE 9 0.0113
203 HAEMOPERITONEUM 9 0.0112
204 EXCESSIVE GRANULATION TISSUE 9 0.0112
205 INCISION SITE HAEMORRHAGE 9 0.0111
206 GASTRIC BYPASS 24 0.0110
207 WITHDRAWAL BLEED 8 0.0110
208 BLADDER IRRITATION 7 0.0109
209 ADVERSE EVENT 996 0.0108
210 ENDOMETRIAL THICKENING 6 0.0108
211 SKIN STRIAE 16 0.0107
212 LIMB DISCOMFORT 322 0.0104
213 WEIGHT INCREASED 2266 0.0101
214 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 24 0.0101
215 POOR QUALITY DEVICE USED 101 0.0101
216 SMEAR CERVIX ABNORMAL 14 0.0099
217 PREGNANCY WITH CONTRACEPTIVE DEVICE 88 0.0098
218 SCAR 168 0.0098
219 VULVOVAGINAL PAIN 46 0.0095
220 ABORTION MISSED 12 0.0094
221 INCISION SITE PAIN 11 0.0094
222 SKIN INJURY 31 0.0093
223 PURULENCE 18 0.0092
224 PERIPHERAL NERVE INJURY 8 0.0091
225 MATERNAL EXPOSURE BEFORE PREGNANCY 62 0.0091
226 ENDOMETRIOSIS 42 0.0088
227 ELECTRIC SHOCK SENSATION 24 0.0086
228 BREAST SWELLING 23 0.0085
229 BREAST MASS 57 0.0085
230 FIBROSIS 26 0.0084
231 LOSS OF LIBIDO 75 0.0083
232 POSTPARTUM HAEMORRHAGE 11 0.0082
233 GENITAL PAIN 12 0.0081
234 DEVICE USE ISSUE 141 0.0081
235 BENIGN INTRACRANIAL HYPERTENSION 10 0.0080
236 GASTRECTOMY 8 0.0080
237 VULVOVAGINAL PRURITUS 40 0.0079
238 OOPHORECTOMY 7 0.0078
239 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 259 0.0077
240 INTRUSIVE THOUGHTS 9 0.0076
241 ABNORMAL WITHDRAWAL BLEEDING 7 0.0076
242 LABELLED DRUG-DRUG INTERACTION ISSUE 11 0.0076
243 ACNE 571 0.0075
244 PELVIC INFLAMMATORY DISEASE 11 0.0074
245 HAEMORRHAGIC DISORDER 8 0.0074
246 VASCULAR PAIN 7 0.0073
247 DISCOMFORT 447 0.0073
248 EXPIRED DEVICE USED 24 0.0072
249 DEATH NEONATAL 10 0.0072
250 SURGERY 421 0.0072
251 PELVIC PAIN 130 0.0071
252 SUSPECTED PRODUCT QUALITY ISSUE 13 0.0071
253 NERVE INJURY 78 0.0070
254 ACNE CYSTIC 21 0.0070
255 LIBIDO DISORDER 9 0.0069
256 BENIGN BREAST NEOPLASM 7 0.0069
257 BREAST DISCOMFORT 7 0.0068
258 AXILLARY MASS 7 0.0067
259 AFFECTIVE DISORDER 53 0.0067
260 OVERWEIGHT 36 0.0067
261 NEEDLE ISSUE 195 0.0067
262 VULVOVAGINAL SWELLING 12 0.0066
263 AFFECT LABILITY 62 0.0064
264 EXPIRED PRODUCT ADMINISTERED 212 0.0064
265 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 293 0.0063
266 HAEMORRHAGE 650 0.0062
267 HYPOAESTHESIA 909 0.0061
268 APPLICATION SITE SCAB 13 0.0060
269 ABDOMINAL PAIN LOWER 150 0.0059
270 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 8 0.0059
271 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 36 0.0059
272 PAIN IN EXTREMITY 1731 0.0059
273 EMBEDDED DEVICE 58 0.0058
274 PURULENT DISCHARGE 25 0.0058
275 TENDERNESS 59 0.0057
276 HAIR GROWTH ABNORMAL 39 0.0056
277 ANORGASMIA 15 0.0055
278 CERVICAL DYSPLASIA 12 0.0055
279 PILOERECTION 6 0.0055
280 MICROCEPHALY 7 0.0055
281 VULVOVAGINAL DISCOMFORT 24 0.0054
282 LIBIDO INCREASED 11 0.0054
283 WEIGHT ABNORMAL 13 0.0054
284 EMOTIONAL DISORDER 165 0.0053
285 ADHESION 8 0.0053
286 BLOODY DISCHARGE 6 0.0052
287 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 90 0.0052
288 MIGRAINE 497 0.0052
289 NEURALGIA 126 0.0052
290 GALACTORRHOEA 33 0.0051
291 PAPILLOEDEMA 23 0.0051
292 BREAST CYST 9 0.0051
293 LIMB INJURY 137 0.0050
294 HAEMORRHAGE IN PREGNANCY 7 0.0049
295 TEARFULNESS 21 0.0049
296 PAPILLOMA VIRAL INFECTION 8 0.0048
297 EXPOSURE DURING BREAST FEEDING 16 0.0048
298 MIGRAINE WITH AURA 13 0.0048
299 UTERINE DISORDER 11 0.0047
300 TRICHORRHEXIS 13 0.0047
301 IATROGENIC INJURY 6 0.0047
302 DEPRESSION SUICIDAL 16 0.0046
303 DEPRESSED MOOD 243 0.0046
304 HIRSUTISM 6 0.0045
305 HYPERPHAGIA 18 0.0045
306 PRODUCT CONTAMINATION 16 0.0045
307 APPENDICECTOMY 16 0.0045
308 MATERNAL EXPOSURE DURING PREGNANCY 399 0.0045
309 IRON DEFICIENCY 20 0.0044
310 FOOD CRAVING 23 0.0044
311 MENOPAUSAL SYMPTOMS 10 0.0043
312 DEPRESSION 962 0.0042
313 CONNECTIVE TISSUE DISORDER 6 0.0042
314 NERVE COMPRESSION 39 0.0042
315 CEREBELLAR HAEMORRHAGE 6 0.0042
316 CONTRAINDICATED PRODUCT PRESCRIBED 7 0.0042
317 TONSILLAR HYPERTROPHY 7 0.0042
318 FOOD AVERSION 7 0.0041
319 WEIGHT FLUCTUATION 43 0.0041
320 WEIGHT LOSS POOR 21 0.0041
321 SELF-INJURIOUS IDEATION 17 0.0040
322 PARAESTHESIA 630 0.0040
323 IMPAIRED HEALING 131 0.0040
324 INTRACRANIAL PRESSURE INCREASED 22 0.0039
325 OCCUPATIONAL EXPOSURE TO PRODUCT 25 0.0039
326 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 27 0.0038
327 NEGATIVE THOUGHTS 11 0.0038
328 FOREIGN BODY 15 0.0037
329 PRODUCT PRESCRIBING ERROR 88 0.0037
330 INJURY ASSOCIATED WITH DEVICE 75 0.0037
331 CRYING 133 0.0037
332 OBESITY 58 0.0036
333 ACCIDENT AT WORK 8 0.0036
334 INCORRECT ROUTE OF DRUG ADMINISTRATION 128 0.0036
335 UTERINE LEIOMYOMA 26 0.0036
336 CAESAREAN SECTION 41 0.0035
337 BIPOLAR DISORDER 38 0.0035
338 MENOPAUSE 9 0.0035
339 HYSTERECTOMY 30 0.0035
340 MUSCLE SPASMS 633 0.0034
341 BREAST DISORDER 7 0.0034
342 PRURITUS GENITAL 8 0.0034
343 PREGNANCY 68 0.0034
344 PULMONARY INFARCTION 8 0.0034
345 INDURATION 6 0.0034
346 PRE-ECLAMPSIA 16 0.0034
347 INVASIVE DUCTAL BREAST CARCINOMA 9 0.0033
348 THROMBOPHLEBITIS SUPERFICIAL 10 0.0033
349 INCREASED APPETITE 63 0.0033
350 MEDICAL DEVICE PAIN 7 0.0033
351 SEBORRHOEA 12 0.0033
352 DISORGANISED SPEECH 6 0.0033
353 CONTUSION 307 0.0032
354 NARCOLEPSY 6 0.0032
355 PRODUCT LOT NUMBER ISSUE 7 0.0032
356 INFECTIOUS MONONUCLEOSIS 7 0.0031
357 HEADACHE 1953 0.0031
358 MOTION SICKNESS 6 0.0031
359 ANGER 105 0.0031
360 SKIN EROSION 10 0.0031
361 PRODUCT USE ISSUE 578 0.0031
362 VULVOVAGINAL MYCOTIC INFECTION 12 0.0030
363 DEVICE DEFECTIVE 52 0.0030
364 MONOPLEGIA 13 0.0030
365 ANAESTHETIC COMPLICATION 8 0.0030
366 DYSMORPHISM 7 0.0030
367 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 602 0.0030
368 SKIN WARM 17 0.0029
369 APPETITE DISORDER 19 0.0029
370 THROMBOPHLEBITIS 10 0.0028
371 SKIN HYPERTROPHY 8 0.0028
372 DEPRESSIVE SYMPTOM 10 0.0028
373 DRUG ADMINISTRATION ERROR 87 0.0028
374 PANIC ATTACK 103 0.0028
375 REPRODUCTIVE COMPLICATION ASSOCIATED WITH DEVICE 10 0.0028
376 ALCOHOLISM 12 0.0028
377 SUICIDAL IDEATION 256 0.0028
378 VASODILATATION 7 0.0028
379 ABDOMINAL PAIN 646 0.0028
380 IRRITABILITY 165 0.0027
381 BIPOLAR I DISORDER 6 0.0027
382 SENSORY LOSS 22 0.0027
383 PREMATURE DELIVERY 43 0.0027
384 RASH GENERALISED 69 0.0027
385 DEVICE RELATED INFECTION 41 0.0027
386 PRODUCT USE IN UNAPPROVED INDICATION 653 0.0026
387 BACK PAIN 604 0.0026
388 PROCEDURAL PAIN 72 0.0026
389 SKIN DISCOMFORT 7 0.0026
390 THERAPEUTIC PRODUCT INEFFECTIVE 10 0.0026
391 SKIN WRINKLING 7 0.0026
392 ANXIETY 727 0.0026
393 VENOUS THROMBOSIS 10 0.0025
394 FURUNCLE 20 0.0025
395 EXPOSURE DURING PREGNANCY 156 0.0025
396 CYST 31 0.0025
397 FRUSTRATION TOLERANCE DECREASED 20 0.0025
398 VITAMIN B12 DEFICIENCY 10 0.0025
399 MAJOR DEPRESSION 18 0.0025
400 SCAB 28 0.0025
401 RETINAL VEIN OCCLUSION 7 0.0024
402 INJECTION SITE INFECTION 8 0.0024
403 WOUND 68 0.0024
404 MENTAL DISORDER 104 0.0024
405 POST-TRAUMATIC STRESS DISORDER 16 0.0024
406 ABDOMINAL PAIN UPPER 491 0.0024
407 PERSONALITY CHANGE 22 0.0024
408 AORTIC VALVE INCOMPETENCE 10 0.0023
409 POOR PERIPHERAL CIRCULATION 10 0.0023
410 STAPHYLOCOCCAL INFECTION 77 0.0023
411 ABDOMINAL DISTENSION 242 0.0023
412 FOETAL DEATH 12 0.0023
413 GESTATIONAL DIABETES 11 0.0023
414 CELLULITIS 116 0.0023
415 DEVICE FAILURE 35 0.0023
416 OVERDOSE 494 0.0023
417 ERYTHEMA NODOSUM 8 0.0023
418 WEIGHT DECREASED 633 0.0023
419 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
420 EXPOSURE VIA BREAST MILK 9 0.0023
421 SKIN INFECTION 25 0.0022
422 FEELING OF BODY TEMPERATURE CHANGE 13 0.0022
423 OROPHARYNGEAL DISCOMFORT 20 0.0022
424 PRODUCT ADMINISTRATION INTERRUPTED 17 0.0022
425 QUALITY OF LIFE DECREASED 29 0.0022
426 VULVOVAGINAL BURNING SENSATION 13 0.0021
427 LACERATION 20 0.0021
428 MENINGIOMA 33 0.0021
429 LYME DISEASE 7 0.0021
430 ANXIETY DISORDER 7 0.0021
431 DEVICE PHYSICAL PROPERTY ISSUE 16 0.0021
432 SKIN ATROPHY 12 0.0021
433 LIMB OPERATION 10 0.0021
434 MASS 29 0.0021
435 ALOPECIA 406 0.0021
436 BILIARY COLIC 6 0.0021
437 DIZZINESS 1028 0.0021
438 LIGAMENT RUPTURE 9 0.0020
439 SKIN ODOUR ABNORMAL 8 0.0020
440 CHOLECYSTECTOMY 23 0.0020
441 DERMATITIS ALLERGIC 25 0.0020
442 LOSS OF EMPLOYMENT 6 0.0020
443 PERIPHERAL SWELLING 306 0.0020
444 HOT FLUSH 149 0.0020
445 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 351 0.0019
446 MOVEMENT DISORDER 62 0.0019
447 YELLOW SKIN 9 0.0019
448 CHEST PAIN 354 0.0019
449 SPINAL DISORDER 18 0.0019
450 MUSCLE FATIGUE 8 0.0019
451 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 133 0.0019
452 HUNGER 26 0.0019
453 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
454 PAROSMIA 14 0.0019
455 PRESYNCOPE 45 0.0018
456 DYSPHEMIA 8 0.0018
457 NAUSEA 1431 0.0018
458 SENSORY DISTURBANCE 29 0.0018
459 PROCEDURAL HAEMORRHAGE 7 0.0018
460 ABNORMAL WEIGHT GAIN 22 0.0018
461 SENSATION OF FOREIGN BODY 15 0.0018
462 IMPAIRED WORK ABILITY 38 0.0018
463 EPILEPSY 54 0.0018
464 POOR QUALITY SLEEP 38 0.0018
465 PRE-EXISTING CONDITION IMPROVED 11 0.0018
466 PHLEBITIS 9 0.0018
467 DERMATITIS CONTACT 20 0.0018
468 CARDIAC VALVE DISEASE 10 0.0017
469 ROAD TRAFFIC ACCIDENT 73 0.0017
470 EATING DISORDER 37 0.0017
471 PHARYNGEAL SWELLING 17 0.0017
472 JOINT INJURY 37 0.0017
473 PREMATURE BABY 52 0.0017
474 CONTRAINDICATED PRODUCT ADMINISTERED 52 0.0017
475 PAIN 1047 0.0017
476 NERVOUSNESS 89 0.0017
477 THROMBOSIS 137 0.0017
478 MATERNAL DRUGS AFFECTING FOETUS 13 0.0017
479 GALLBLADDER DISORDER 30 0.0017
480 PERIPHERAL COLDNESS 23 0.0017
481 SUBCUTANEOUS ABSCESS 8 0.0017
482 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7 0.0017
483 ADVERSE REACTION 22 0.0017
484 STILLBIRTH 8 0.0017
485 SKIN HYPERPIGMENTATION 14 0.0016
486 PSYCHIATRIC SYMPTOM 12 0.0016
487 CEREBRAL DISORDER 12 0.0016
488 OCULAR ICTERUS 7 0.0016
489 SCRATCH 17 0.0016
490 ECCHYMOSIS 11 0.0016
491 IMPULSIVE BEHAVIOUR 6 0.0016
492 BURNING SENSATION 112 0.0016
493 SYNCOPE 159 0.0016
494 PARANASAL SINUS DISCOMFORT 6 0.0016
495 HYPERAESTHESIA 13 0.0016
496 SCREAMING 10 0.0016
497 PROCEDURAL COMPLICATION 12 0.0016
498 MUSCLE TWITCHING 36 0.0016
499 DRUG PRESCRIBING ERROR 30 0.0016
500 PANIC DISORDER 6 0.0015
501 LOCAL SWELLING 27 0.0015
502 FEELING ABNORMAL 368 0.0015
503 NODULE 20 0.0015
504 FUNGAL INFECTION 51 0.0015
505 URTICARIA 256 0.0015
506 DECREASED INTEREST 9 0.0015
507 BLOOD IRON DECREASED 18 0.0015
508 MUSCLE STRAIN 13 0.0015
509 GASTROINTESTINAL MOTILITY DISORDER 8 0.0015
510 ARTHROPOD BITE 11 0.0015
511 FOETAL GROWTH RESTRICTION 9 0.0015
512 HOMICIDAL IDEATION 6 0.0015
513 THERAPEUTIC RESPONSE UNEXPECTED 66 0.0015
514 PIGMENTATION DISORDER 9 0.0015
515 FOREIGN BODY IN REPRODUCTIVE TRACT 13 0.0015
516 ABSCESS 23 0.0014
517 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 79 0.0014
518 PRODUCT DOSE OMISSION ISSUE 422 0.0014
519 HAEMATOMA 37 0.0014
520 PAPULE 10 0.0014
521 SKIN DISCOLOURATION 65 0.0014
522 ABDOMINAL TENDERNESS 7 0.0014
523 IRON DEFICIENCY ANAEMIA 13 0.0014
524 BRAIN FOG 22 0.0014
525 NEUROLOGICAL SYMPTOM 8 0.0014
526 INFUSION SITE PAIN 18 0.0014
527 PARANOIA 24 0.0014
528 IMPAIRED QUALITY OF LIFE 20 0.0014
529 PHARYNGITIS STREPTOCOCCAL 15 0.0014
530 PRODUCT PACKAGING ISSUE 13 0.0014
531 GRIP STRENGTH DECREASED 12 0.0014
532 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
533 DEVICE MALFUNCTION 95 0.0014
534 ACCIDENT 16 0.0013
535 MUSCULOSKELETAL DISCOMFORT 23 0.0013
536 POSTOPERATIVE WOUND INFECTION 9 0.0013
537 PRODUCT LABEL ISSUE 9 0.0013
538 INJECTION SITE VESICLES 8 0.0013
539 ABNORMAL LOSS OF WEIGHT 9 0.0013
540 HIDRADENITIS 12 0.0013
541 HYPOKINESIA 19 0.0013
542 FOOD POISONING 7 0.0013
543 CHEILITIS 7 0.0013
544 SEXUAL DYSFUNCTION 15 0.0013
545 SKIN REACTION 18 0.0013
546 BLEPHAROSPASM 8 0.0013
547 INITIAL INSOMNIA 13 0.0013
548 DEVICE USE ERROR 44 0.0013
549 SWELLING 118 0.0013
550 DRUG INTERACTION 199 0.0013
551 PROCTALGIA 8 0.0012
552 HEAD DISCOMFORT 22 0.0012
553 NIGHT SWEATS 40 0.0012
554 INTENTIONAL SELF-INJURY 25 0.0012
555 PULMONARY EMBOLISM 117 0.0012
556 SKIN DISORDER 41 0.0012
557 POLLAKIURIA 51 0.0012
558 BLINDNESS TRANSIENT 9 0.0012
559 CARPAL TUNNEL SYNDROME 17 0.0012
560 LIGAMENT SPRAIN 12 0.0012
561 HEREDITARY ANGIOEDEMA 13 0.0012
562 GENERAL SYMPTOM 9 0.0012
563 LOCALISED INFECTION 29 0.0012
564 ERYSIPELAS 6 0.0012
565 COLD SWEAT 21 0.0012
566 URINE ODOUR ABNORMAL 7 0.0012
567 PRODUCT ADMINISTRATION ERROR 24 0.0012
568 HYPERSOMNIA 34 0.0012
569 THROAT TIGHTNESS 32 0.0012
570 NECK PAIN 66 0.0012
571 MOTOR DYSFUNCTION 12 0.0012
572 FACIAL PARALYSIS 10 0.0012
573 VOMITING 550 0.0012
574 DECREASED APPETITE 267 0.0011
575 HYPERSENSITIVITY 213 0.0011
576 FOETAL EXPOSURE DURING PREGNANCY 93 0.0011
577 PALLOR 31 0.0011
578 MICTURITION URGENCY 13 0.0011
579 TRICUSPID VALVE INCOMPETENCE 9 0.0011
580 RENAL PAIN 12 0.0011
581 OBSESSIVE-COMPULSIVE DISORDER 9 0.0011
582 FEAR 30 0.0011
583 BEHAVIOUR DISORDER 6 0.0011
584 APATHY 16 0.0011
585 WOUND INFECTION 12 0.0011
586 PALPITATIONS 128 0.0011
587 HAEMOGLOBIN ABNORMAL 7 0.0011
588 INCREASED TENDENCY TO BRUISE 10 0.0011
589 FEEDING DISORDER 22 0.0011
590 HYPERPROLACTINAEMIA 7 0.0011
591 PAIN OF SKIN 29 0.0011
592 FEELING DRUNK 8 0.0011
593 PRODUCT DOSE OMISSION 70 0.0011
594 INFLUENZA LIKE ILLNESS 88 0.0011
595 PRURITUS GENERALISED 23 0.0011
596 CHROMATURIA 24 0.0011
597 MUSCLE TIGHTNESS 17 0.0010
598 SKIN MASS 7 0.0010
599 BREAST CANCER FEMALE 28 0.0010
600 SKIN IRRITATION 48 0.0010
601 BACK DISORDER 17 0.0010
602 MUSCULOSKELETAL CHEST PAIN 16 0.0010
603 CONCUSSION 8 0.0010
604 DYSURIA 38 0.0010
605 MUSCULOSKELETAL PAIN 54 0.0010
606 VITAMIN D DEFICIENCY 10 0.0010
607 INJURY 72 0.0010
608 SKIN FISSURES 20 0.0010
609 ILLNESS 105 0.0010
610 RESPIRATION ABNORMAL 7 0.0010
611 ERYTHEMA 208 0.0010
612 ENCEPHALITIS 7 0.0010
613 SKIN LACERATION 11 0.0010
614 FATIGUE 785 0.0010
615 LOW BIRTH WEIGHT BABY 8 0.0010
616 AGGRESSION 50 0.0010
617 RASH PRURITIC 54 0.0010
618 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29 0.0010
619 PHARYNGITIS 12 0.0010
620 PULMONARY ARTERIAL HYPERTENSION 14 0.0010
621 APPENDICITIS 9 0.0010
622 SEIZURE 111 0.0010
623 FLANK PAIN 9 0.0010
624 SECRETION DISCHARGE 12 0.0010
625 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 46 0.0010
626 DEEP VEIN THROMBOSIS 62 0.0010
627 INFECTION 138 0.0010
628 INFUSION SITE ERYTHEMA 8 0.0009
629 MOBILITY DECREASED 68 0.0009
630 SPINAL PAIN 11 0.0009
631 WRONG TECHNIQUE IN DRUG USAGE PROCESS 34 0.0009
632 DIZZINESS POSTURAL 9 0.0009
633 ABDOMINAL DISCOMFORT 155 0.0009
634 PYELONEPHRITIS 8 0.0009
635 HEPATITIS ACUTE 6 0.0009
636 CHEST DISCOMFORT 94 0.0009
637 KIDNEY INFECTION 18 0.0009
638 FOOD ALLERGY 7 0.0009
639 DERMATITIS 19 0.0009
640 PHOTOPHOBIA 17 0.0009
641 MEDICATION ERROR 50 0.0009
642 LOSS OF CONSCIOUSNESS 115 0.0009
643 INFLAMMATION 46 0.0009
644 OCULAR DISCOMFORT 10 0.0009
645 OROPHARYNGEAL PAIN 82 0.0009
646 ECZEMA 46 0.0009
647 ASTHENIA 330 0.0009
648 INTERNAL HAEMORRHAGE 10 0.0009
649 VISION BLURRED 120 0.0009
650 DISTURBANCE IN ATTENTION 47 0.0009
651 NEOPLASM 10 0.0009
652 MALAISE 381 0.0009
653 FEELING HOT 53 0.0009
654 MUSCLE DISORDER 7 0.0009
655 HYPOAESTHESIA ORAL 13 0.0009
656 POLYURIA 7 0.0009
657 URINARY TRACT INFECTION 145 0.0008
658 PSYCHOTIC DISORDER 25 0.0008
659 FOOT FRACTURE 16 0.0008
660 PRODUCT PHYSICAL ISSUE 17 0.0008
661 HEMIPLEGIA 7 0.0008
662 SUICIDE ATTEMPT 51 0.0008
663 SLEEP DISORDER 59 0.0008
664 PANIC REACTION 6 0.0008
665 PRURITUS 319 0.0008
666 LYMPHADENOPATHY 29 0.0008
667 LIP SWELLING 27 0.0008
668 HEART RATE INCREASED 80 0.0008
669 HYPERHIDROSIS 104 0.0008
670 THINKING ABNORMAL 15 0.0008
671 MIDDLE INSOMNIA 15 0.0008
672 BLISTER 45 0.0008
673 DRUG DOSE OMISSION 132 0.0008
674 INSOMNIA 212 0.0008
675 MITRAL VALVE INCOMPETENCE 9 0.0008
676 MUSCULAR WEAKNESS 90 0.0008
677 HAEMATEMESIS 20 0.0008
678 SLEEP APNOEA SYNDROME 15 0.0008
679 BODY TEMPERATURE INCREASED 16 0.0008
680 BOWEL MOVEMENT IRREGULARITY 6 0.0008
681 DISSOCIATION 6 0.0008
682 POST PROCEDURAL COMPLICATION 15 0.0008
683 BLINDNESS UNILATERAL 11 0.0008
684 GENITAL HAEMORRHAGE 10 0.0008
685 DYSTONIA 15 0.0008
686 POST PROCEDURAL HAEMORRHAGE 9 0.0008
687 ANAEMIA 147 0.0008
688 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
689 RASH 330 0.0008
690 HYPOTHYROIDISM 24 0.0008
691 VERTIGO 45 0.0007
692 RASH ERYTHEMATOUS 35 0.0007
693 SKIN LESION 20 0.0007
694 APPLICATION SITE PAIN 16 0.0007
695 ATELECTASIS 7 0.0007
696 EOSINOPHIL COUNT INCREASED 6 0.0007
697 AUTOIMMUNE DISORDER 7 0.0007
698 DEVICE ADHESION ISSUE 11 0.0007
699 THYROID DISORDER 11 0.0007
700 BLINDNESS 29 0.0007
701 ABNORMAL BEHAVIOUR 28 0.0007
702 IMPAIRED DRIVING ABILITY 8 0.0007
703 ANGINA PECTORIS 20 0.0007
704 HYPERTHYROIDISM 10 0.0007
705 EYELID OEDEMA 8 0.0007
706 GROIN PAIN 6 0.0007
707 ANKYLOSING SPONDYLITIS 9 0.0007
708 FEELING COLD 19 0.0007
709 FACIAL PAIN 6 0.0007
710 EYE SWELLING 25 0.0007
711 THIRST 12 0.0007
712 TRANSFUSION 7 0.0007
713 INJECTION SITE DISCOMFORT 7 0.0007
714 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
715 LIP DRY 6 0.0007
716 OPTIC NEURITIS 6 0.0007
717 MENTAL IMPAIRMENT 16 0.0007
718 FIBROMYALGIA 16 0.0007
719 DRUG DISPENSING ERROR 10 0.0007
720 HEMIPARESIS 11 0.0006
721 APPLICATION SITE ERYTHEMA 17 0.0006
722 ARTHRALGIA 268 0.0006
723 DELUSION 10 0.0006
724 PULMONARY THROMBOSIS 7 0.0006
725 CHOLELITHIASIS 21 0.0006
726 GASTROINTESTINAL PAIN 7 0.0006
727 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
728 BLOOD URINE PRESENT 12 0.0006
729 SWELLING FACE 41 0.0006
730 EPISTAXIS 46 0.0006
731 RETCHING 13 0.0006
732 HAEMOPTYSIS 17 0.0006
733 MANIA 10 0.0006
734 SKIN HAEMORRHAGE 9 0.0006
735 DERMATITIS ATOPIC 32 0.0006
736 UPPER LIMB FRACTURE 12 0.0006
737 EAR INFECTION 16 0.0006
738 HYPOTONIA 6 0.0006
739 JOINT RANGE OF MOTION DECREASED 8 0.0006
740 HEPATIC STEATOSIS 11 0.0006
741 RASH MACULAR 20 0.0006
742 HALLUCINATION, VISUAL 12 0.0006
743 SOMNOLENCE 114 0.0006
744 GENERALISED OEDEMA 7 0.0006
745 VISUAL IMPAIRMENT 70 0.0006
746 HYPERTENSION 119 0.0006
747 IRRITABLE BOWEL SYNDROME 12 0.0006
748 PARALYSIS 8 0.0006
749 DECREASED ACTIVITY 6 0.0006
750 PARAESTHESIA ORAL 8 0.0006
751 RESTLESSNESS 20 0.0005
752 DYSPNOEA 308 0.0005
753 ACCIDENTAL EXPOSURE TO PRODUCT 56 0.0005
754 DENTAL CARIES 6 0.0005
755 VIRAL INFECTION 18 0.0005
756 INJECTION SITE INDURATION 7 0.0005
757 RASH MACULO-PAPULAR 12 0.0005
758 LETHARGY 31 0.0005
759 IMMUNODEFICIENCY 8 0.0005
760 BLOOD PRESSURE INCREASED 81 0.0005
761 INTENTIONAL DOSE OMISSION 15 0.0005
762 MUSCULOSKELETAL DISORDER 10 0.0005
763 CONVULSION 30 0.0005
764 PYREXIA 181 0.0005
765 JAUNDICE 14 0.0005
766 NIGHTMARE 18 0.0005
767 PHARYNGEAL OEDEMA 8 0.0005
768 GASTROINTESTINAL DISORDER 46 0.0005
769 CYANOSIS 8 0.0005
770 URINARY INCONTINENCE 15 0.0005
771 PNEUMOTHORAX 8 0.0005
772 ISCHAEMIC STROKE 9 0.0005
773 ANAPHYLACTIC SHOCK 13 0.0005
774 HALLUCINATION, AUDITORY 8 0.0005
775 BLOOD PRESSURE ABNORMAL 10 0.0005
776 CYSTITIS 16 0.0005
777 UNEVALUABLE EVENT 38 0.0005
778 TINNITUS 23 0.0005
779 SKIN EXFOLIATION 42 0.0005
780 TACHYCARDIA 44 0.0005
781 CHILLS 58 0.0005
782 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 9 0.0005
783 RASH PAPULAR 11 0.0005
784 APPLICATION SITE PRURITUS 11 0.0005
785 AGRANULOCYTOSIS 9 0.0005
786 BACTERIAL INFECTION 9 0.0005
787 SWOLLEN TONGUE 15 0.0005
788 OEDEMA 26 0.0005
789 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
790 AMNESIA 31 0.0005
791 BRAIN OEDEMA 6 0.0005
792 MUSCLE ATROPHY 6 0.0005
793 INJECTION SITE IRRITATION 6 0.0005
794 ADVERSE DRUG REACTION 42 0.0005
795 TREMOR 77 0.0005
796 DIPLOPIA 12 0.0005
797 HAEMORRHOIDS 9 0.0005
798 BREAST CANCER 43 0.0005
799 MYALGIA 78 0.0005
800 FLATULENCE 26 0.0005
801 NEPHROLITHIASIS 21 0.0005
802 INSURANCE ISSUE 7 0.0005
803 DYSPEPSIA 45 0.0005
804 GASTRITIS 12 0.0005
805 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
806 EYE HAEMORRHAGE 6 0.0004
807 LIVER FUNCTION TEST ABNORMAL 13 0.0004
808 EMOTIONAL DISTRESS 54 0.0004
809 BLOOD BILIRUBIN INCREASED 12 0.0004
810 GASTROENTERITIS VIRAL 8 0.0004
811 HEART RATE IRREGULAR 10 0.0004
812 TOOTHACHE 8 0.0004
813 RESTLESS LEGS SYNDROME 8 0.0004
814 GINGIVAL BLEEDING 6 0.0004
815 MULTIPLE SCLEROSIS 21 0.0004
816 SCIATICA 7 0.0004
817 GASTRIC DISORDER 15 0.0004
818 ABNORMAL DREAMS 12 0.0004
819 RESPIRATORY DISORDER 13 0.0004
820 PRODUCT COMPLAINT 11 0.0004
821 INJECTION SITE PRURITUS 29 0.0004
822 FLUID RETENTION 22 0.0004
823 BLOOD POTASSIUM DECREASED 13 0.0004
824 CONJUNCTIVITIS 8 0.0004
825 PAIN IN JAW 12 0.0004
826 HEPATOCELLULAR INJURY 6 0.0004
827 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
828 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
829 AGITATION 31 0.0004
830 COAGULOPATHY 7 0.0004
831 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
832 ARTHROPATHY 23 0.0004
833 PRESCRIBED OVERDOSE 8 0.0004
834 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
835 ILL-DEFINED DISORDER 25 0.0004
836 EAR PAIN 8 0.0004
837 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 29 0.0004
838 ANGIOEDEMA 18 0.0004
839 DISABILITY 8 0.0004
840 ECONOMIC PROBLEM 6 0.0004
841 PRODUCT AVAILABILITY ISSUE 9 0.0004
842 BLOOD PRESSURE DECREASED 26 0.0004
843 NASOPHARYNGITIS 72 0.0004
844 INFLUENZA 43 0.0004
845 DEAFNESS 10 0.0004
846 DRUG EXPOSURE DURING PREGNANCY 13 0.0004
847 HEAD INJURY 12 0.0004
848 DYSSTASIA 11 0.0004
849 HYPOACUSIS 16 0.0004
850 FREQUENT BOWEL MOVEMENTS 10 0.0004
851 TREATMENT NONCOMPLIANCE 20 0.0004
852 MUSCULOSKELETAL STIFFNESS 32 0.0004
853 APHASIA 11 0.0004
854 PHOTOSENSITIVITY REACTION 6 0.0004
855 HAEMATOCHEZIA 20 0.0004
856 TOOTH DISORDER 8 0.0004
857 BONE PAIN 21 0.0004
858 THERAPEUTIC PRODUCT EFFECT DECREASED 16 0.0004
859 THROAT IRRITATION 16 0.0004
860 FALL 118 0.0004
861 EYE PAIN 20 0.0004
862 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
863 HAEMATOCRIT DECREASED 7 0.0004
864 NERVOUS SYSTEM DISORDER 11 0.0004
865 INJECTION SITE SWELLING 27 0.0004
866 DRUG INTOLERANCE 34 0.0004
867 INJECTION SITE REACTION 24 0.0003
868 EXPOSURE VIA SKIN CONTACT 9 0.0003
869 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
870 ANHEDONIA 9 0.0003
871 RHINORRHOEA 22 0.0003
872 INJECTION SITE WARMTH 7 0.0003
873 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
874 NEUROPATHY PERIPHERAL 32 0.0003
875 CONSTIPATION 73 0.0003
876 FLUSHING 34 0.0003
877 CEREBROVASCULAR ACCIDENT 56 0.0003
878 INJECTION SITE ERYTHEMA 41 0.0003
879 DRY SKIN 44 0.0003
880 GAIT INABILITY 11 0.0003
881 INJECTION SITE MASS 12 0.0003
882 NASAL CONGESTION 19 0.0003
883 FEELING JITTERY 6 0.0003
884 COVID-19 55 0.0003
885 LOWER LIMB FRACTURE 6 0.0003
886 SNEEZING 7 0.0003
887 HAEMOGLOBIN DECREASED 32 0.0003
888 GASTROOESOPHAGEAL REFLUX DISEASE 25 0.0003
889 ASTHMA 35 0.0003
890 INTENTIONAL PRODUCT MISUSE 27 0.0003
891 ANAPHYLACTIC REACTION 17 0.0003
892 MEMORY IMPAIRMENT 41 0.0003
893 EYE PRURITUS 10 0.0003
894 CONFUSIONAL STATE 48 0.0003
895 DYSGEUSIA 22 0.0003
896 PRODUCT SUBSTITUTION ISSUE 17 0.0003
897 DYSPHAGIA 28 0.0003
898 DRUG INEFFECTIVE 388 0.0003
899 COLITIS ULCERATIVE 13 0.0003
900 DIABETES MELLITUS 22 0.0003
901 WITHDRAWAL SYNDROME 12 0.0003
902 INJECTION SITE URTICARIA 7 0.0003
903 DEHYDRATION 38 0.0003
904 HYPOPHAGIA 7 0.0003
905 SINUSITIS 28 0.0003
906 DRY MOUTH 22 0.0003
907 LABORATORY TEST ABNORMAL 8 0.0003
908 DYSKINESIA 11 0.0003
909 BRONCHITIS 20 0.0003
910 TYPE 2 DIABETES MELLITUS 9 0.0003
911 PANCREATITIS ACUTE 6 0.0003
912 DYSARTHRIA 10 0.0003
913 DYSPNOEA EXERTIONAL 10 0.0003
914 SKIN BURNING SENSATION 19 0.0003
915 JOINT SWELLING 32 0.0003
916 DIARRHOEA 170 0.0003
917 INJECTION SITE RASH 8 0.0003
918 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
919 DELIRIUM 9 0.0003
920 DISEASE RECURRENCE 12 0.0003
921 SPEECH DISORDER 13 0.0002
922 ACCIDENTAL OVERDOSE 9 0.0002
923 ASPARTATE AMINOTRANSFERASE INCREASED 13 0.0002
924 EYE DISORDER 8 0.0002
925 SEPSIS 27 0.0002
926 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
927 VISUAL ACUITY REDUCED 8 0.0002
928 URINARY RETENTION 8 0.0002
929 CARDIAC DISORDER 22 0.0002
930 JOINT STIFFNESS 6 0.0002
931 LIVER DISORDER 10 0.0002
932 GAIT DISTURBANCE 43 0.0002
933 DYSPHONIA 13 0.0002
934 COUGH 62 0.0002
935 CONDITION AGGRAVATED 67 0.0002
936 BALANCE DISORDER 19 0.0002
937 INTENTIONAL OVERDOSE 14 0.0002
938 THERAPEUTIC RESPONSE DECREASED 13 0.0002
939 PSORIASIS 28 0.0002
940 THERAPY CESSATION 11 0.0002
941 OCULAR HYPERAEMIA 10 0.0002
942 NEOPLASM MALIGNANT 14 0.0002
943 PRODUCTIVE COUGH 10 0.0002
944 INJECTION SITE PAIN 64 0.0002
945 TREATMENT FAILURE 17 0.0002
946 HYPOTENSION 41 0.0002
947 WHEEZING 12 0.0002
948 DRY EYE 10 0.0002
949 HALLUCINATION 15 0.0002
950 HEPATIC FAILURE 6 0.0002
951 LACRIMATION INCREASED 6 0.0002
952 OEDEMA PERIPHERAL 24 0.0002
953 OFF LABEL USE 172 0.0002
954 HEPATIC ENZYME INCREASED 13 0.0002
955 PANCREATITIS 10 0.0002
956 INJECTION SITE BRUISING 15 0.0002
957 HEPATIC FUNCTION ABNORMAL 7 0.0002
958 RECTAL HAEMORRHAGE 8 0.0002
959 DRUG EFFECT DECREASED 10 0.0002
960 COLITIS 7 0.0002
961 DISORIENTATION 7 0.0002
962 PSORIATIC ARTHROPATHY 7 0.0002
963 COGNITIVE DISORDER 8 0.0002
964 HEART RATE DECREASED 6 0.0002
965 BLOOD GLUCOSE DECREASED 8 0.0002
966 HYPOGLYCAEMIA 8 0.0002
967 MULTIPLE SCLEROSIS RELAPSE 11 0.0002
968 HERPES ZOSTER 9 0.0002
969 THERAPY INTERRUPTED 11 0.0002
970 PLATELET COUNT DECREASED 16 0.0001
971 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
972 BLOOD GLUCOSE INCREASED 27 0.0001
973 BLOOD CREATININE INCREASED 9 0.0001
974 INJECTION SITE HAEMORRHAGE 11 0.0001
975 BLOOD CHOLESTEROL INCREASED 6 0.0001
976 DRUG WITHDRAWAL SYNDROME 11 0.0001
977 LUNG DISORDER 6 0.0001
978 HOSPITALISATION 18 0.0001
979 INCORRECT DOSE ADMINISTERED 26 0.0001
980 PNEUMONIA 36 0.0001
981 DRUG ABUSE 9 0.0001
982 MYOCARDIAL INFARCTION 18 0.0001
983 ARTHRITIS 8 0.0001
984 PLEURAL EFFUSION 6 0.0001
985 CARDIAC FAILURE 7 0.0001
986 COMPLETED SUICIDE 7 0.0001
987 RENAL IMPAIRMENT 7 0.0001
988 PRODUCT STORAGE ERROR 7 0.0001
989 ACUTE KIDNEY INJURY 11 0.0001
990 RHEUMATOID ARTHRITIS 8 0.0001
991 RENAL FAILURE 9 0.0001
992 TOXICITY TO VARIOUS AGENTS 8 0.0000
993 DEATH 26 0.0000